Jillian C Green

Ms. Jillian C Green


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JJJonathan Joyce
Jonathan Joyce
GMGreyson Moore
Greyson Moore
PGPoorna Goswami
Poorna Goswami
THTelvin Harrell
Telvin Harrell
TTTina Taylor
Tina Taylor
ABAndrea Bertke
Andrea Bertke
Neurological symptoms associated with COVID-19, acute and long term, suggest SARS-CoV-2 affects both the peripheral and central nervous systems (PNS/CNS). Although studies have shown olfactory and hematogenous invasion into the CNS, coinciding with neuroinflammation, little attention has been paid to susceptibility of the PNS to infection or to its contribution to CNS invasion. Here we show that sensory and autonomic neurons in the PNS are susceptible to productive infection with SARS-CoV-2 and outline physiological and molecular mechanisms mediating neuroinvasion. Our infection of K18-hACE2 mice, wild-type mice, and golden Syrian hamsters, as well as primary peripheral sensory and autonomic neuronal cultures, show viral RNA, proteins, and infectious virus in PNS neurons, satellite glial cells, and functionally connected CNS tissues. Additionally, we demonstrate, in vitro, that neuropilin-1 facilitates SARS-CoV-2 neuronal entry. SARS-CoV-2 rapidly invades the PNS prior to viremia, establishes a productive infection in peripheral neurons, and results in sensory symptoms often reported by COVID-19 patients.

1 October 2026 in Viruses
Verified
Journal Article
Open access
PDF file
JGJillian C Green
Jillian C Green
GMGreyson Moore
Greyson Moore
MIMatthew Irwin
Matthew Irwin
JJJonathan Joyce
Jonathan Joyce
ABAndrea Bertke
Andrea Bertke
Herpes simplex virus 1 (HSV-1) establishes latency in both sensory and sympathetic neurons. Stress is strongly correlated with HSV-1 reactivation. The acute stress hormone epinephrine initiates HSV-1 reactivation in vitro upon activating at least two adrenergic receptors (ARs), including α2, β1, and/or β2-AR. To determine if blocking these receptors could reduce HSV-1 recurrences, we infected guinea pigs vaginally with HSV-1 (17+) and, after latency was established, treated them daily with atipamezole (specific α2-AR inhibitor), propranolol (nonspecific β-AR inhibitor), or atipamezole/propranolol combined. Clinical recurrences decreased in the treatment groups compared to untreated: atipamezole (29.3%, p = 0.123), propranolol (43.6%, p = 0.021), and atipamezole/propranolol (39.1%, p = 0.021). No significant differences were observed between groups in HSV-1 viral load in pelvic ganglia, or in transcription of the latency-associated transcript (LAT) in guinea pigs that were asymptomatic when euthanized, suggesting AR inhibitors did not affect latency. In guinea pigs euthanized during recurrences, viral DNA was similar between groups in sensory ganglia but reduced in sympathetic ganglia in treatment groups compared to untreated, suggesting that reactivation still occurred in sensory but was limited in sympathetic neurons in AR inhibitor-treated animals. The use of adrenergic beta blockers may be a useful therapeutic to reduce HSV-1 clinical recurrences.